We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

41 hedge funds and large institutions have $16.1M invested in Cocrystal Pharma in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

0.4% less ownership

Funds ownership: 1.71% → 1.31% (-0.4%)

2% less funds holding

Funds holding: 42 → 41 (-1)

36% less capital invested

Capital invested by funds: $25M → $16.1M (-$8.94M)

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
11
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$267K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$203K
3
Millennium Management
Millennium Management
New York
+$150K
4
Mariner
Mariner
Kansas
+$110K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$63.4K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.44M
2
SM
Sabby Management
Florida
-$1.04M
3
ACM
Altium Capital Management
New York
-$970K
4
Renaissance Technologies
Renaissance Technologies
New York
-$625K
5
Squarepoint
Squarepoint
New York
-$242K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
26
Two Sigma Securities
New York
$19K +$19.8K +1,498 New
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
$17K +$53 +4 +0.3%
Victory Capital Management
28
Victory Capital Management
Texas
$14K -$754 -57 -5%
BRWA
29
B. Riley Wealth Advisors
Florida
$14K – – –
UBS Group
30
UBS Group
Switzerland
$13K +$1.97K +149 +18%
Jane Street
31
Jane Street
New York
$12K +$12.2K +924 New
CL
32
CIM LLC
New York
$10K – – –
Osaic Holdings
33
Osaic Holdings
Arizona
$6K +$26 +2 +0.4%
CYG
34
Clean Yield Group
Vermont
$5K – – –
AIC
35
Archer Investment Corporation
Indiana
$1.05K – – –
Wells Fargo
36
Wells Fargo
California
$1K -$1.31K -99 -55%
NL
37
NVWM LLC
Pennsylvania
$1K – – –
JPLA
38
Joseph P. Lucia & Associates
New York
$1K +$119 +9 +11%
JP Morgan Chase
39
JP Morgan Chase
New York
$1K +$1.26K +95 New
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
– -$3.44M -229,175 Closed
ACM
41
Altium Capital Management
New York
– -$970K -64,667 Closed
Squarepoint
42
Squarepoint
New York
– -$242K -16,139 Closed
Charles Schwab
43
Charles Schwab
California
– -$50K -3,270 Closed
HI
44
Harbour Investments
Wisconsin
– -$3K -167 Closed
1
2

COCP Hedge Fund Activity: Q3 2021 in Review

41 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q3 2021, worth a combined $16.1M — down 36% from $25M a quarter earlier.

Fund positioning in COCP was balanced in Q3 2021: 6 funds opened new positions, 6 closed out, 11 added to existing stakes and 11 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $267K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $3.44M sold.

  • 41 institutional investors held Cocrystal Pharma (COCP) as of Q3 2021, down from 42 in Q2 2021.
  • Funds reported $16.1M of Cocrystal Pharma stock for Q3 2021, down 36% quarter-over-quarter.
  • 6 funds opened new Cocrystal Pharma positions in Q3 2021 and 6 closed out, a net change of 0 holders.
  • The largest Cocrystal Pharma buyer in Q3 2021 was Geode Capital Management, an estimated $267K added.
  • The largest Cocrystal Pharma seller in Q3 2021 was Alyeska Investment Group, an estimated $3.44M sold.

Based on aggregated 13F filings for Q3 2021.